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Abstract
Non-obstructive coronary artery disease (CAD) which is mostly called cardiac syndrome X (CSX) is noted in about 30% of men and 40%-60% of women 
and seems to be incremental. In addition, frequent myocardial perfusion defects with various levels of severity are often seen in this disease. Recently, 
we noticed that the frequency of migraine in patients with CSX was noticeably higher than in healthy people and in CAD patients. This may support 
the evolving story that CSX is related to migraine and to chest pain and that CSX and migraine may have a similar pathophysiology. Hence, myocardial 
perfusion imaging could be used as a complement any diagnostic test to support the relation between CSX and migraine. 
Introduction
Among individuals with chest pain who underwent coronary angiography to rule out  probable ischemic heart dise-ase (IHD), cases of  normal  or  non-obstructive  coronary artery disease (CAD) were noted in about 30% of men and 40%-60% of women and this percentage seems to be increasing [1]. Many authors refer to this condition as cardiac 
syndrome X (CSX), although there is no consensus on this terminology [2].   
 Cardiac syndrome X is described as a typical chest pain either with a normal or near normal coronary angiogram  and with 
or without electrocardiographic  (ECG)  ndings, or as an atypical chest pain with a normal or near normal coronary angiogra-
m a positive non-invasive exercise tolerance test or myocardial perfusion scan and with or without ECG  ndings [3].  
Patients with di erent clinical  ndings  such as coronary artery spasm (Prinzmetal's or variant angina), left ventricular hy-
pertrophy, hypertension, valvular heart disease, diabetes mellitus and bundle branch block are not included in this syn-
drome [3]. What's more, this subgroup of patients, based on reoccurring evidence has worse outcome [4].  
The precise pathophysiological mechanism of CSX is not well understood. Chest pain has been due to microvascular dys-
function, metabolic abnormalities, endothelial dysfunction and infection [3, 5 -7 ]. In addition, transcellular, intracellular diso-
rders of the cardiomyocytes cause angina in these patients. New technologies which include  integration of genomic, epi-
genomic, transcriptional, and metabolomic data allow to launch patient-centered management in the milieu of precision 
medicine [4,8]. 
In a prior study of ours CSX patients, frequent perfusion defects with various levels of severity were often observed. More 
than 30% of these individuals had at least one perfusion defect [9]. It has also been reported that myocardial perfusion abnor-
malities were patchily distributed throughout myocardium [10].   
Cardiac syndrome X and migraine
Recently, we demonstrated that the frequency of migraine in patients with CSX was appreciably higher than in healthy peo-
ple and CAD patient groups. This suggests that CSX may be a manifestation of  migraine or of migraine equivalents [11].
Parallel to that, Roldau (2014) assessed the manifestations and outcomes and also evaluated the association between angi-
na and headache as a manifestation of migraine exacerbation. They studied 33 patients with migraine headaches at an earlier 
onset than angina. All had taken medications prior to visiting the emergency department (ED) [12]. 
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The authors, concluded that angina can be a complication 
of migraine, the treatment should be centered on migraine 
control and migraine should be included in the di erential 
diagnosis list for chest pain [12].
In addition, Rose et al. (2004) proposed a new chapter in 
this evolving story. In a population-based investigation in 
four societies of aging African Americans and whites (the At-
herosclerosis Risk in Communities study), they determined 
that migraine headaches are related to angina, which was st-
ronger in cases of migraine with aura. However, there was no 
relationship between a lifetime history of migraine or other 
headaches and coronary heart disease events [13]. These and 
other authors concluded that migraine is related to chest dis-
comfort but not to cardiac events [13-17]. Thus, it is recom-
mended that neurologists should investigate and also mana-
ge vascular risk factors in migraines, rule out silent myocardial 
ischemia when appropriate, and utilize Triptan therapy for in-
dividuals with moderate or severe migraines (US Headache 
Consortium Guidelines) [15].
As noted above, the exact pathogenesis of CSX remains un-
certain, but the two main hypotheses are: a) Coronary micro-
vascular dysfunction, and b) Abnormal cardiac pain sensi-
tivity [18]. Nevertheless, the link of CSX and migraine has not 
been well addressed in the literature. The term  cardiac mig-
raine  de nes the angina-like chest pain with ischemic chan-
ge and normal coronary angiography in individuals  compla-
ining of migraine headaches [19].
Messages for nuclear medicine practitioners
We have studied by nuclear medicine, cardiology and neuro-
logy studies the history of migraine headaches in a nuclear 
cardiology laboratory and found several new patients diag-
nosed with CSX who had prior history of migraine. Interes-
tingly, some patients developed migraine headaches after 
Nicorandil administration, as reported earlier [20]. 
This may complement the evolving story of CSX and mig-
raine and suggest that chest pain and migraine could have a 
similar pathophysiology. Myocardial perfusion imaging can 
be applied as a complement to other diagnostic and clinical 
examinations by studying coronary ischemia in  ow limiting 
CAD. 
As a rule, these coronary ischemia defects are considered 
as false-positive based on coronary angiography and would 
account for the low speci city of MPI in ruling out the iden-
ti cation of CAD [21-31]. Such a term may not be reasonable 
even in the absence of known prior conditions such as small 
vascular disease. It is recommended that these issues, espe-
cially cardiac physiologists should be further studied. 
Furthermore, borderline perfusion defects on MPI, in pati-
ents with a history of migraine without known small vascular 
diseases should be more studied [32-35].
Graf et al prospectively assessed the incidence of a dysfun-
ctional microcirculation and persuaded predictive parame-
ters of a diminished CFR in 79 patients with typical angina 
and a normal angiogram and 10 control subjects; CFR was 
calculated by 13N-ammonia rest/dipyridamole PET and as-
sociated with clinical parameters. In about two thirds of pati-
ents, anginal pain can be clari ed by a decreased CFR. Risk 
factors have a cumulative negative impact on CFR. A clinical 
cardiac risk factor analysis permits estimation of individual 
probability of microvascular dysfunction in a signi cant pro-
portion of these patients. Nevertheless, CFR measurements 
are advised for those with an intermediate number of risk 
factors (NRF) [36].  
Since  a  near-normal  or  normal  angiogram because of 
its  less than very good  diagnostic results is not diagnostic of 
CSX additional diagnostic modalities should be kept in mind 
in short-term and long-term management of CSX [4].  Clini-
cal cardiology approach is always important [8, 37-39]. 
In conclusion, while there are many diagnostic and patho-
physiological data as for the relationship between CSX and 
migraine it seems that migraine is related to angina but not 
to coronary artery disease.
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